Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD

Aug 30, 2007

Opko Health, Inc. Announces Early Termination of Hart-Scott-Rodino Waiting Period for Proposed Purchase of Shares by Dr. Phillip Frost

Jul 12, 2007

Opko Health Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD

Jul 11, 2007
RSS
  • Prev
    • 1...
    • 39
    • 40
    • 41
    • 42
    • 43
    • 44
    • 45
    • 46
    • 47
    • 48

    OPKO HEALTH, INC.
    4400 Biscayne Boulevard
    Miami, FL 33137

    305-575-4100
    contact@opko.com

    © 2023 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap